Axiom Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$717K Hold
1,853
– – 0.48% 49
2026
Q1
$542K Buy
+1,853
New +$609K 0.41% 52
2019
Q3
– Sell
-3,661
Closed -$1.04M – 282
2019
Q2
$1.04M Buy
3,661
+324
+10% +$88.5K 0.19% 135
2019
Q1
$957K Buy
+3,337
New +$965K 0.18% 133

Other funds holding ELV

Axiom Investment Management's ELV Position: Q2 2026 in Review

Axiom Investment Management held its Elevance Health (ELV) position steady in Q2 2026 at 1,853 shares worth $717K. The position accounts for 0.48% of the portfolio, ranked #49.

Axiom Investment Management first reported a position in ELV in Q1 2019 and has held it in 4 quarters since. The position peaked at $1.04M in Q2 2019. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Axiom Investment Management held 1,853 shares of Elevance Health worth $717K as of Q2 2026.
  • Axiom Investment Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.48% of Axiom Investment Management's portfolio in Q2 2026, its #49 holding.
  • Axiom Investment Management first reported a position in Elevance Health in Q1 2019 and has held it in 4 quarters since.
  • Axiom Investment Management's Elevance Health position peaked at $1.04M in Q2 2019.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.